Naheeda Haque

Head of CTU

Naheeda Haque began her career five years ago as a Vaccine Logistics Officer for TyVAC, a Phase III trial that aimed to evaluate the effectiveness of the ViTyphoid conjugate vaccine in the field.

The goal of the trial was to provide insight and support for the use of the vaccine as a control measure for enteric fever in endemic areas, with the aim of reducing global morbidity and mortality from enteric fever.

She also worked on the TyVOID trial, which aimed to assess the medium-term effectiveness of a Vi-Polysaccharide Conjugate Vaccine in preventing typhoid infections in Nepali children.

Over time, she transitioned into a Quality Assurance Officer role and now leads Clinical Trial Units (CTUs).

Publications

Mila Shakya, Merryn Voysey, Katherine Theiss-Nyland, Rachel Colin-Jones, Dikshya Pant, Anup Adhikari, Susan Tonks, Yama F Mujadidi, Peter O’Reilly, Olga Mazur, Sarah Kelly, Xinxue Liu, Archana Maharjan, Ashata Dahal, Naheeda Haque, Anisha Pradhan, Suchita Shrestha, Manij Joshi, Nicola Smith, Jennifer Hill, Jenny Clarke, Lisa Stockdale, Elizabeth Jones, Timothy Lubinda, Binod Bajracharya, Sabina Dongol, Abhilasha Karkey, Stephen Baker, Gordan Dougan, Virginia E Pitzer, Kathleen M Neuzil, Shrijana Shrestha, Buddha Basnyat, Andrew J Pollard; TyVAC Nepal Team

Lancet Glob Health

November 1, 2021

DOI: 10.1016/S2214-109X(21)00346-6

Shakya M, Colin-Jones R, Theiss-Nyland K, Voysey M, Pant D, Smith N, Liu X, Tonks S, Mazur O, Farooq YG, Clarke J, Hill J, Adhikari A, Dongol S, Karkey A, Bajracharya B, Kelly S, Gurung M, Baker S, Neuzil KM, Shrestha S, Basnyat B, Pollard AJ; TyVAC Nepal Study Team

N Engl J Med

December 5, 2019

DOI: 10.1056/NEJMoa1905047

LEARN MORE

Projects